Manager, IT Business Analysis at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Keen insight into pharmaceutical Process Development and technological trends, particularly in cloud computing, Agile methodologies, data analytics, AI/ML
Exceptional analytical and critical thinking skills for use case analysis, functional design specification, and process mapping
In-depth understanding of business needs and objectives in general business and technology realms
Ability to bridge technology solutions with business strategies to enhance operational efficiency and achieve strategic goals
Experience supporting Gilead business strategies and operations through evaluation, analysis, and planning of technology, process, and business needs
Skills in collaboration with business leads and IT partners to align technology solutions with business objectives

Responsibilities

Lead the evaluation, analysis, and planning of technology, process, and related business needs
Conduct use case analysis, functional design specification, process mapping, testing, and validation of business technology solutions
Act as lead business analyst for assigned business groups or IT domains, participating in evaluation and feasibility analysis for new or updated systems/applications
Orchestrate allocation and coordination of IT resources to ensure project timelines and business goals are met
Conduct post-implementation reviews to assess solution effectiveness, monitor operations for optimization, and lead continuous improvement efforts
Coordinate and manage internal and external IT resources to support assigned projects
Support and model a culture of high-performance, data-driven decision-making, value-driven prioritization, quality governance, and compliance
Serve as strategic technology partner to PDM Technical Development (Process Development) business capability
Work with business colleagues to align technology direction with business goals and define relevant, effective solutions
Mature existing systems and services to drive business value
Responsible for ideation, planning, and development of technology solutions

Skills

IT Business Analysis

Business Requirements Analysis

Use Case Analysis

Process Evaluation

Stakeholder Collaboration

Technology Alignment

Business Strategy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free